124 related articles for article (PubMed ID: 38494064)
1. Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis.
Di Giorgio C; Morretta E; Lupia A; Bellini R; Massa C; Urbani G; Bordoni M; Marchianò S; Lachi G; Rapacciuolo P; Finamore C; Sepe V; Chiara Monti M; Moraca F; Natalizi N; Graziosi L; Distrutti E; Biagioli M; Catalanotti B; Donini A; Zampella A; Fiorucci S
Biochem Pharmacol; 2024 May; 223():116134. PubMed ID: 38494064
[TBL] [Abstract][Full Text] [Related]
2. Leukemia inhibitory factor (LIF), cardiotrophin-1, and oncostatin M share structural binding determinants in the immunoglobulin-like domain of LIF receptor.
Plun-Favreau H; Perret D; Diveu C; Froger J; Chevalier S; Lelièvre E; Gascan H; Chabbert M
J Biol Chem; 2003 Jul; 278(29):27169-79. PubMed ID: 12707269
[TBL] [Abstract][Full Text] [Related]
3. Affinity maturation of leukemia inhibitory factor and conversion to potent antagonists of signaling.
Fairlie WD; Uboldi AD; McCoubrie JE; Wang CC; Lee EF; Yao S; De Souza DP; Mifsud S; Metcalf D; Nicola NA; Norton RS; Baca M
J Biol Chem; 2004 Jan; 279(3):2125-34. PubMed ID: 14585833
[TBL] [Abstract][Full Text] [Related]
4. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
5. Contributions of leukemia inhibitory factor receptor and oncostatin M receptor to signal transduction in heterodimeric complexes with glycoprotein 130.
Hermanns HM; Radtke S; Haan C; Schmitz-Van de Leur H; Tavernier J; Heinrich PC; Behrmann I
J Immunol; 1999 Dec; 163(12):6651-8. PubMed ID: 10586060
[TBL] [Abstract][Full Text] [Related]
6. Expression of leukemia inhibitory factor (LIF)/interleukin-6 family cytokines and receptors during in vitro osteogenesis: differential regulation by dexamethasone and LIF.
Liu F; Aubin JE; Malaval L
Bone; 2002 Jul; 31(1):212-9. PubMed ID: 12110437
[TBL] [Abstract][Full Text] [Related]
7. Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.
Dhingra K; Sahin A; Emami K; Hortobagyi GN; Estrov Z
Breast Cancer Res Treat; 1998 Mar; 48(2):165-74. PubMed ID: 9596488
[TBL] [Abstract][Full Text] [Related]
8. Dual oncostatin M (OSM) receptors. Cloning and characterization of an alternative signaling subunit conferring OSM-specific receptor activation.
Mosley B; De Imus C; Friend D; Boiani N; Thoma B; Park LS; Cosman D
J Biol Chem; 1996 Dec; 271(51):32635-43. PubMed ID: 8999038
[TBL] [Abstract][Full Text] [Related]
9. Receptor subunit-specific action of oncostatin M in hepatic cells and its modulation by leukemia inhibitory factor.
Wang Y; Robledo O; Kinzie E; Blanchard F; Richards C; Miyajima A; Baumann H
J Biol Chem; 2000 Aug; 275(33):25273-85. PubMed ID: 10854424
[TBL] [Abstract][Full Text] [Related]
10. Influence of subunit combinations on signaling by receptors for oncostatin M, leukemia inhibitory factor, and interleukin-6.
Kuropatwinski KK; De Imus C; Gearing D; Baumann H; Mosley B
J Biol Chem; 1997 Jun; 272(24):15135-44. PubMed ID: 9182534
[TBL] [Abstract][Full Text] [Related]
11. Discovery of BAR502, as potent steroidal antagonist of leukemia inhibitory factor receptor for the treatment of pancreatic adenocarcinoma.
Di Giorgio C; Bellini R; Lupia A; Massa C; Bordoni M; Marchianò S; Rosselli R; Sepe V; Rapacciuolo P; Moraca F; Morretta E; Ricci P; Urbani G; Monti MC; Biagioli M; Distrutti E; Catalanotti B; Zampella A; Fiorucci S
Front Oncol; 2023; 13():1140730. PubMed ID: 36998446
[TBL] [Abstract][Full Text] [Related]
12. A family of leukemia inhibitory factor-binding peptides that can act as antagonists when conjugated to poly(ethylene glycol).
Fairlie WD; Uboldi AD; Hemmings GJ; Smith BJ; Martin HM; Morgan PO; Baca M
Biochemistry; 2003 Nov; 42(45):13193-201. PubMed ID: 14609330
[TBL] [Abstract][Full Text] [Related]
13. Phosphorylation of the human leukemia inhibitory factor (LIF) receptor by mitogen-activated protein kinase and the regulation of LIF receptor function by heterologous receptor activation.
Schiemann WP; Graves LM; Baumann H; Morella KK; Gearing DP; Nielsen MD; Krebs EG; Nathanson NM
Proc Natl Acad Sci U S A; 1995 Jun; 92(12):5361-5. PubMed ID: 7777512
[TBL] [Abstract][Full Text] [Related]
14. Evidence for heterodimeric association of leukemia inhibitory factor (LIF) receptor and gp130 in the mouse uterus for LIF signaling during blastocyst implantation.
Song H; Lim H
Reproduction; 2006 Feb; 131(2):341-9. PubMed ID: 16452727
[TBL] [Abstract][Full Text] [Related]
15. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
[TBL] [Abstract][Full Text] [Related]
16. Activation of cytokine signaling through leukemia inhibitory factor receptor (LIFR)/gp130 attenuates ischemic brain injury in rats.
Suzuki S; Yamashita T; Tanaka K; Hattori H; Sawamoto K; Okano H; Suzuki N
J Cereb Blood Flow Metab; 2005 Jun; 25(6):685-93. PubMed ID: 15716858
[TBL] [Abstract][Full Text] [Related]
17. Role of leukemia inhibitory factor and its receptor in mouse primordial germ cell growth.
Cheng L; Gearing DP; White LS; Compton DL; Schooley K; Donovan PJ
Development; 1994 Nov; 120(11):3145-53. PubMed ID: 7720558
[TBL] [Abstract][Full Text] [Related]
18. Pregnancy-dependent expression of leukaemia inhibitory factor (LIF), LIF receptor-beta and interleukin-6 (IL-6) messenger ribonucleic acids in the porcine female reproductive tract.
Modric T; Kowalski AA; Green ML; Simmen RC; Simmen FA
Placenta; 2000 May; 21(4):345-53. PubMed ID: 10833369
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of pinopodes and leukemia inhibitory factor, as well as its receptor, in human endometrium.
Aghajanova L; Stavreus-Evers A; Nikas Y; Hovatta O; Landgren BM
Fertil Steril; 2003 Mar; 79 Suppl 1():808-14. PubMed ID: 12620495
[TBL] [Abstract][Full Text] [Related]
20. Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis.
Di Giorgio C; Marchianò S; Marino E; Biagioli M; Roselli R; Bordoni M; Bellini R; Urbani G; Zampella A; Distrutti E; Donini A; Graziosi L; Fiorucci S
Front Oncol; 2022; 12():939969. PubMed ID: 35847866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]